- Joined
- Jun 3, 2007
- Messages
- 4,843
- Reaction score
- 3,269
So imagine you create a drug/system/liposome that can elute a drug of your choice over a certain amount of days of your choice.
Now imagine you decide that you are going to place a local anesthetic in that liposome. You go to the shelf of local anesthetics and take a look at them all to decide which one you will choose....and you SHOULD be thinking "duration of action shouldn't come into play since I COMPLETELY CONTROL duration of action, so what I MOST care about is safety profile and therapeutic index and side effect profile. That is all that matters."
That is how that thought process should work.
And I have always been baffled how ridiculous it was that the folks who were first to market with a liposomal local anesthetic somehow decided to choose the most neurotoxic, cardiotoxic, and lowest therapeutic index LA on the shelf. Could there have been a worse decision made that day?
Okay...so be it. The folks that invented Exparel are idiots. Accept it and move on. Let's hope that scientists in the lab who come up with new extended release LA's are somewhat more enlightened. In fact, they don't even have to be smart. They just have to be - not REALLY REALLY STUPID.
Yet....guess what?
The newest extended release product (HTX-011) has bupiviciane in it as well. I cannot freakin' believe it. I just can't.....
What the?
Now imagine you decide that you are going to place a local anesthetic in that liposome. You go to the shelf of local anesthetics and take a look at them all to decide which one you will choose....and you SHOULD be thinking "duration of action shouldn't come into play since I COMPLETELY CONTROL duration of action, so what I MOST care about is safety profile and therapeutic index and side effect profile. That is all that matters."
That is how that thought process should work.
And I have always been baffled how ridiculous it was that the folks who were first to market with a liposomal local anesthetic somehow decided to choose the most neurotoxic, cardiotoxic, and lowest therapeutic index LA on the shelf. Could there have been a worse decision made that day?
Okay...so be it. The folks that invented Exparel are idiots. Accept it and move on. Let's hope that scientists in the lab who come up with new extended release LA's are somewhat more enlightened. In fact, they don't even have to be smart. They just have to be - not REALLY REALLY STUPID.
Yet....guess what?
The newest extended release product (HTX-011) has bupiviciane in it as well. I cannot freakin' believe it. I just can't.....
What the?